The use of recombinant erythropoietin in the reduction of transfusion rates in craniosynostosis repair in infants and children [17] (multiple letters)

Plastic and Reconstructive Surgery

Volumn 111, Issue 7, 2003, Pages 2485-2487

  Przybylo, H J ^a,b   Przybylo, Jason H ^b   Fearon, Jeffrey A ^c   Weinthal, Joel ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRANIOFACIAL SYNOSTOSIS; FLUID THERAPY; HUMAN; INTRAOPERATIVE PERIOD; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CRANIOSYNOSTOSES; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINOMETRY; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS;

EID: 0037981466     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000063134.27372.45     Document Type: Letter

References (0)